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Abstract 
Purpose: Radial scar and radial sclerosis (RS) are considered benign breast lesions with proliferative features. There is 
sparse literature on frequency of cancer upgrade in these patients without atypical features found on image-guided 
needle biopsy. This study retrospectively reviews cases of isolated RS diagnosed on needle biopsy and evaluates the 
cancer upgrade after subsequent surgical excision.
Methods: We conducted a retrospective cross-sectional study of cases with an isolated RS diagnosis based on nee-
dle biopsy and subsequent surgical pathology among all patients between January 1, 2009 and December 31, 2013. 
Patients with concomitant atypia, lobular carcinoma in situ on core biopsy, complete excision of very small RS with 
needle biopsy, and radiology-pathology discordance were excluded. An upgrade from the needle biopsy of RS was 
defined as surgical excision pathology that revealed ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC), 
and/or invasive lobular carcinoma (ILC).
Results: 10,921 image-guided needle biopsy pathology reports were collected and 88 patients (0.81 %) were identi-
fied as having isolated RS. Of these 88 patients, 63 (72 %) underwent excision. The upgrade rate to cancer on subse-
quent surgical excision was 1.59 % (1/63) for DCIS; 0 % (0/63) for IDC; and 0 % (0/63) ILC. Twenty-five patients who did 
not undergo surgical excision had stable imaging studies with mean (±SD) 26 (±20) months follow up.
Conclusions: Isolated radial scar on needle biopsy may not warrant routine surgical excision given relatively low 
cancer upgrade rates. Advancement in breast imaging, pathology and multidisciplinary approaches to care may effec-
tively guide non-surgical management of RS.
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Background
Breast cancer is the most common cancer diagnosed 
and the second leading cause of cancer-related deaths 
in women in the United States (Howlader et  al. 2011). 
Women with a history of benign breast disease (BBD) are 
at an increased risk for developing breast cancer. A well-
established BBD classification system was developed by 
Dupont and Page, which consists of (1) non-proliferative 
disease, (2) proliferative disease without atypia, and (3) 
proliferative disease with atypia (Dupont and Page 1985). 
Dupont and Page, and others reviewed more than 10,000 
benign breast biopsies and they found that women with 
BBD with atypia had a breast cancer relative risk 4.4 
times higher than that of the general population (Dupont 
and Page 1985; Degnim et al. 2007; Morgan et al. 2012).
Quantifying the risk of breast cancer of proliferative 
disease without atypia has been an ongoing challenge 
(Degnim et al. 2007; Morgan et al. 2012; Krishnamurthy 
et  al. 2012). The lack of consensus on management of 
these patients with benign and high risk breast disease 
can be demonstrated by a survey taken by the Ameri-
can Society of Breast Surgeons in 2011 (Krishnamurthy 
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et  al. 2012). Approximately 1020 practicing breast sur-
geons were asked about their preferred management of 
these breast lesions, including atypical lobular hyperpla-
sia, atypical ductal hyperplasia, lobular carcinoma in situ 
(LCIS), flat epithelial atypia, radial scar and papilloma 
without atypia (Krishnamurthy et al. 2012). Surgical exci-
sion biopsy was recommended for most patients when 
needle core biopsy showed these high risk lesions were 
present. Surgical excisional biopsy was recommended in 
approximately 63 % of cases for papilloma without atypia, 
75 % for atypical lobular hyperplasia, 70 % for LCIS, 72 % 
for flat epithelial atypia, and 76 % for radial scar (Krishna-
murthy et al. 2012). These variations of practice pattern 
are due to lack of robust research outcome studies.
At our institution, there has been a growing interest 
in assessing patient outcome in the setting of a multidis-
ciplinary breast team, and determining need for surgi-
cal excision of radial scar or radial sclerosis (RS) of the 
breast. As illustrated in Fig. 1, RS is a histological diag-
nosis characterized by an irregular spiculated pattern of 
epithelial proliferation radiation from a central fibroelas-
totic core with entrapped and distorted ducts (Morgan 
et  al. 2012; López-Medina et  al. 2006; Resetkova et  al. 
2011; Linda et  al. 2010). Clinically, it is challenging to 
differentiate from carcinoma due to spiculated charac-
teristics on imaging studies. In the modern era, percu-
taneous image guided core needle biopsy has essentially 
replaced upfront surgical biopsy for tissue diagnosis and 
to exclude malignancy. Controversy still exists regarding 
the need for surgical excision after a core needle biopsy 
diagnosis of isolated RS. Current literature on cancer 
upgrade rates is limited due to very small study sample 
size, study samples consisting of a mixture of both surgi-
cal biopsy and core needle biopsy cases, and study sam-
ples consisting of both isolated RS without atypia and RS 
with atypia (Krishnamurthy et  al. 2012; López-Medina 
et al. 2006; Resetkova et al. 2011; Linda et al. 2010; Sohn 
et al. 2010; Doyle et al. 2007; Douglas-Jones et al. 2007; 
Berg et al. 2008; Becker et al. 2006; Cawson et al. 2003; 
Brenner et  al. 2002). Therefore, these studies do not 
address the question of the surgical cancer upgrade rate 
of isolated RS after core needle biopsy. Many cancer 
institutions, similar to ours, resort to routine policy to 
recommend surgical excisional biopsy when RS is found 
on core needle biopsy to safely exclude malignancy. How-
ever, surgery is not without potential complications, and 
economic costs and benefits remain unclear.
Purpose
The purpose of this study is to retrospectively review iso-
lated RS diagnosis found on image-guided percutaneous 
core needle biopsies, and determine cancer upgrade after 
subsequent surgical excision.
Methods
This study was reviewed and approved by the Sutter 
Health Central Area Institutional Review Committee 
(IRC). We also obtained administrative and institutional 
approval from the approved study site(s), including Rose-
ville, Sacramento, Davis, Auburn, Amador, Solano, and 
Yuba City. Data was obtained through a query of the Sut-
ter electronic medical record system (EPIC), and Diag-
nostic Pathology Medical Group (DPMG) electronic 
medical database (Claris) to establish the cases meeting 
the study inclusion criteria. Patient paper charts were 
retrieved to extract information not available in elec-
tronic medical records.
The study design was retrospective and observational. 
Our study utilized available aggregate database analysis 
from EPIC, DPMG and patient charts to obtain patient 
demographic and medical history. Adult females who 
underwent needle biopsy at Sutter Imaging Center 
from Jan 1, 2009 through Dec 31, 2013 were included. 
Core needle biopsy and surgical pathology results with 
diagnosis of isolated RS were analyzed. Exclusion cri-
teria included male gender, previous ipsilateral cancer 
diagnosis 6 months prior to breast biopsy, patients with 
concomitant atypia or LCIS on core biopsy, complete 
excision of very small RS with core needle biopsy and 
radiology-pathology discordance. An upgrade from the 
core biopsy of isolated RS was defined as surgical exci-
sion pathology that revealed ductal carcinoma in  situ 
(DCIS), invasive ductal carcinoma (IDC), and/or invasive 
lobular carcinoma (ILC).
To evaluate the impact of needle size and upgrade in 
cancer, the size (gauge) of the core needle and the type 
of image technology were noted. Breast lesions biopsied 
stereotactically were obtained with the use of the 14, 11 
and 8 gauge vacuum assisted device (Hologic, Marlbor-
ough, MA). Stereotatic biopsies were performed while 
the patient lay prone on a dedicated stereotactic table 
(Hologic, Marlborough, MA). Ultrasound guided biopsy 
(Bard, Murray Hill, NJ) and Breast MRI guided biopsy 
(Hologic, Marlborough, MA) were used. After core sam-
ples were obtained, a small biopsy marker (Hologic, Mar-
lborough, MA) was placed at the site of the biopsy.
A combined database containing demographic data, 
family history of breast cancer, alcohol/tobacco use, body 
mass index (BMI), pathology, and breast density was 
obtained by linking the EPIC/Clarity and DPMG/Claris 
databases by patient name and date of birth. Missing val-
ues were obtained by EPIC chart review. Cases of radial 
scar were filtered from the pathology report and vali-
dated by chart review.
Descriptive statistics were used to examine and explore 
the data. Chi square Test of Independence (categorical 
variables) and analysis of variance (continuous variables) 
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were used to compare differences between the excision 
and non-excision groups. P values less than 0.05 were 
considered statistically significant.
Results
We identified 10,921 image-guided core needle biopsy 
breast pathology reports from the years 2009 through 
2013, of which 88 patients (0.81  %) were identified as 
having isolated RS diagnosis with radiology-pathology 
concordance. All 88 patients were recommended for sur-
gical excision by the pathologist and radiologist. Of the 
88 patients, 63 (72  %) underwent surgical excision, and 
25 (28  %) did not undergo surgical excision after core 
biopsy.
As illustrated in Table 1, there were no statistically sig-
nificant differences between the abstracted demograph-
ics of those who underwent excision versus those who 
did not. The mean age was 56 years in both groups. The 
majority of patients in both categories were self-reported 
to be White. The average BMI ranged from 27 (excision 
group) to 30 (non-excision group), both of which are 
classified as obese. Between 40 and 43  % of patients in 
each category reported as using alcohol. Among those 
who underwent excision, 59  % were “never smokers” 
versus 40 % among those who did not undergo excision. 
Almost all patients with reported mammographic breast 
density had >25  %. Among patients who underwent a 
surgical excision, 8 % reported a family history of breast 
and ovarian cancer, whereas none of the patients who did 
not undergo surgical excision reported family history.
Of those who did not undergo surgery, all lesions were 
non-palpable and were detected at the time of screening 
mammogram or breast MRI (Table 2). Four patients who 
underwent breast MRI were considered high risk patients 
Fig. 1 a Left breast screening mammogram and compressing view. Left breast mammogram shows non-palpable speculated lesion with radiat-
ing bands. They appear as an asymmetric density or area of architectural distortion without a central mass. Radiating spicules in a background of 
radiolucent fatty tissue create a “black star” appearance. b Ultrasound showing radial scar. Ultrasound shows ill-defined hypoechoic area with or 
without posterior shadowing and associated distortion (which is best demonstrated on coronal view). c Radial scar coronal plane. From left to right: 
Left picture shows ultrasound 1 mm thick slice of conventional imaging. Middle picture shows 2 mm thick slice showing hyperechoic fibroelastosis. 
Left picture shows gross appearance dominated by fibroelastosis. d Haematoxylin-eosin stain of radial scar core needle biopsy. Core needle biopsy 
pathology (original magnification ×100; haematoxylin-eosin stain) shows speculated radial scar with a central nidus of dense fibroelastotic tissue 
and radiating fibrous bands surrounded by “corona” of glandular proliferations and cysts
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with estimated life time risk of developing breast cancer 
(LTRBC) >20  %. As part of American Cancer Society 
Guidelines, these patients undergo breast MRI as adjunct 
to screening mammogram (Saslow et al. 2007). The size 
of abnormalities were all ≤20 mm (2 cm). The majority 
of the lesions were vacuum-assisted biopsies with size 
9–11  g needle and, on average, 4–6 core tissue samples 
removed.
The cancer upgrade rate for both Invasive Ductal Car-
cinoma and Invasive Lobular Carcinoma was 0  %. One 
patient (1.59 % of the total who underwent surgical exci-
sion) was diagnosed with DCIS (Table 3). The lesion was 
initially seen as architectural distortion of 17 mm in size 
on the screening mammogram. The lesion was biop-
sied under breast MRI guidance using Vacuum-assisted 
9 gauge needle with total of 5 core samples removed. 
The 25 patients who did not undergo surgical excision 
had stable imaging studies with mean (±SD) 26 (±20) 
months follow up.
Discussion
In the modern era of medicine, replacing surgical biopsy 
with image-guided core needle biopsy for non-palpable 
lesions initially discovered on screening is no longer 
Table 1 Subject characteristics and risk factors
Characteristic Those who underwent  
surgical excision (n = 63)




 <39 3 (5) 1 (4)
 40–49 19 (30) 7 (28)
 50–59 17 (27) 8 (32)
 60–69 16 (25) 8 (32)
 >70 8 (13) 1 (4)
 Unknown 0 (0) 0 (0)
Age—mean (SD) 56 (12) 56 (10) 0.84
Family history—n (%) 0.23
 No 45 (71) 17 (68)
 Yes 5 (8) 0 (0)
 Unknown 13 (21) 8 (32)
Race/ethnicity—n (%) 0.53
 White 43 (68) 22 (88)
 Hispanic 0 (0) 0 (0)
 American Indian/Alaska Native 1 (2) 0 (0)
 Asian 1 (2) 0 (0)
 African American 2 (3) 0 (0)
 Filipino 1 (2) 0 (0)
 Unknown 15 (24) 3 (12)
BMI—mean (SD) 27 (6) 30 (8) 0.19
Tobacco—n (%) 0.24
 Current 4 (6) 3 (12)
 Never 37 (59) 10 (40)
 History 12 (19) 4 (16)
 Unknown 10 (16) 8 (32)
Active alcohol use—n (%) 0.16
 No 20 (31) 4 (16)
 Yes 27 (43) 10 (40)
 Unknown 16 (25) 11 (44)
Density, mammographic—n (%) 0.29
 <25 % 1 (2) 1 (4)
 >25–50 % 11 (17) 9 (36)
 >50–75 % 39 (62) 12 (48)
 >75 % 3 (5) 0 (0)
 Unknown 9 (14) 3 (12)
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controversial. The American College of Surgeons Com-
mission on Cancer strongly supports this change in clini-
cal practice. However, controversy still exists regarding 
when to surgically excise the residual lesion once core 
needle biopsy reveals proliferative benign breast disease, 
especially isolated RS. Spiculated radiologic characteris-
tics of RS resemble malignancy, and it can be challenging 
to differentiate between this and tubular histotype carci-
noma (López-Medina et  al. 2006). Current literature on 
cancer upgrade rate after surgical excision widely varies 
from 0 to 40 % due to heterogeneous study patient pop-
ulations, including mixture of isolated RS and RS with 
atypia lesions, study patient populations combining RS 
diagnosis from both core and upfront surgical excision 
biopsy, small study sample sizes, and lack of compari-
son between patients who did and did not undergo sur-
gery (Resetkova et al. 2011; Linda et al. 2010; Sohn et al. 
2010; Doyle et  al. 2007; Douglas-Jones et  al. 2007; Berg 
et al. 2008; Becker et al. 2006; Cawson et al. 2003; Bren-
ner et  al. 2002). Our study contributes to the literature 
by (1) evaluating a patient population consisting of only 
isolated RS without atypia and (2) comparing patients 
who did and did not undergo surgery after core needle 
biopsy. Sutter Medical Centers of Sacramento Sierra 
region serves over a million residents in both urban and 
suburban areas. The Sacramento Metropolitan Area is 
the largest in the Central Valley and the fourth largest in 
the state, and these service regions combined represents 
a study population that is generalizable to residents of 
northern California.
The cancer upgrade rates after surgery in our patient 
population with isolated RS found on core needle biopsy 
was 1.59  % (1/63) for DCIS. The histologic feature of 
DCIS was clearly different from tubular histotype his-
tologically. There was no invasive carcinoma cancer 
upgrade.
The relatively low malignancy upgrade rate in this study 
supports the clinical judgment in favor of using large bore 
vacuum assisted core needle biopsy size, sampling at least 
6 cores in the setting of lesion size less than 2  cm, and 
performing post biopsy re-imaging to evaluate residual 
disease after the core needle biopsy has been performed. 
If there is notable residual disease present or discord-
ance, then surgical excision should be performed. Post 
biopsy residual disease on post biopsy imaging would be 
concerning for sampling error risk as studies suggest that 
the proportion of radial scar volume involved by carci-
noma ranges from 3.7 to 16.2 % and carcinoma involved 
the periphery of the lesion (López-Medina et al. 2006).
Our radiologists perform approximately 4–6 core sam-
ples per lesion. On the other hand, Brenner et al. (2002) 
and Becker et  al. (2006) recommends at least 12 core 
specimens using vacuum assisted large core needles (11 
or 14 gauge) to achieve reliable samples. This difference 
Table 2 Imaging and core biopsy characteristics of patients who did not undergo surgery
Initial detection imaging type Indication Type of abnormality Size of abnormality (mm)
Mammogram Screening (n = 21) Cluster of calcifications (n = 9) 5–20
Mass (n = 7) 7–17
Architectural distortion (n = 2) 5–20
Unknown (n = 3) –
Breast MRI High risk patient screening (n = 4) Enhancing nodule (n = 1) 5
Non-mass like enhancement (n = 1) 14
Unknown (n = 2) –
Needle size (n = 16) Type of core biopsy needle Number of core biopsy samples
14 gauge needle 2-Vac 4–6 cores
11 gauge needle 8-Vac 4–6 cores
9 gauge needle 6 (4-Vac and 2-nonVac) 4–6 cores
Unknown size (n = 9) – –
Table 3 Cancer upgrade case after surgical excision
Image type Lesion (size) Biopsy method Caliber of needle # samples Cancer type
Mammogram Architectural distortion (17 mm) MRI guided Vacuum Assisted 9 gauge 5 cores DCIS
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is due to difference in patient population. Our patient 
population consists of radiological lesions with size less 
than 2 cm. Between 4 and 6 core samples for lesions less 
than 2 cm in size may be reliable based on our study find-
ings, and is clinically outweighed by higher risk of bleed-
ing, larger hematoma, and pain associated with greater 
number of core sampling case by case basis. This ques-
tion requires further study in larger samples.
Finally, it is important to consider the 63 patients who 
underwent surgery who did not have cancer. While 
knowledge that the residual area has been completely 
excised and therefore ruled out for cancer is highly ben-
eficial, it is also very important to question in what ways 
we are over-treating our patient population. There are 
potential complications associated with surgery such 
as wound dehiscence, infection, hematoma and pain. 
Also there are potential complications from anesthesia. 
There are personal costs, such as anxiety with associated 
surgery. Additional research studies to quantify these 
impacts is needed as well as additional study in other 
populations, such as different socio-demographic patient 
populations, different approaches to handling RS lesions, 
and different RS lesions radiologic presentations.
Advancement in breast imaging, pathology and mul-
tidisciplinary approaches to care may effectively guide 
non-surgical management of RS diagnosed on core nee-
dle biopsy. Based on our study findings, isolated radial 
scar on core needle biopsy may not warrant routine sur-
gical excision given relatively low cancer upgrade rates. 
These conditions are met when there is an isolated radio-
logic estimation of RS less than 2 cm in size, radiology/
pathology concordance, no associated atypia or LCIS, 
and no palpable lesion (Table 4). We recommend surgi-
cal excisional biopsy when there is a core needle biopsy 
showing RS associated with atypia or LCIS, radiology/
pathology non-concordance, limited sampling (large 
lesion, bleeding during biopsy, notable residual disease), 
palpable lesion, or associated mass on US or breast MRI 
(Table 4).
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